Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueDepreciation & Amortization (IS)Depreciation ExpenseEBIATGross ProfitLeasesLoans and Notes ReceivablesLong-Term Debt IssuancesLong-Term Debt RepaymentsNon-Current ReceivablesOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares IssuedShares OutstandingShares OutstandingShort-Term Debt issuancesShort-Term Debt repaymentsWages, Salaries and Other
Ratios

Cosmos Health (COSM) Accumulated Depreciation & Amortization (2017 - 2025)

Cosmos Health's Accumulated Depreciation & Amortization history spans 9 years, with the latest figure at $2.1 million for Q4 2025.

  • Quarterly results put Accumulated Depreciation & Amortization at $2.1 million for Q4 2025, up 66.1% from a year ago — trailing twelve months through Dec 2025 was $2.1 million (up 66.1% YoY), and the annual figure for FY2025 was $2.1 million, up 66.1%.
  • Accumulated Depreciation & Amortization for Q4 2025 was $2.1 million at Cosmos Health, up from $1.9 million in the prior quarter.
  • In the past five years, Accumulated Depreciation & Amortization ranged from a high of $2.1 million in Q4 2025 to a low of $728069.0 in Q1 2021.
  • The 5-year median for Accumulated Depreciation & Amortization is $983575.5 (2022), against an average of $1.1 million.
  • The sharpest move saw Accumulated Depreciation & Amortization surged 162.61% in 2021, then fell 19.18% in 2023.
  • Year by year, Accumulated Depreciation & Amortization stood at $934473.0 in 2021, then fell by 6.06% to $877823.0 in 2022, then rose by 9.05% to $957255.0 in 2023, then skyrocketed by 33.2% to $1.3 million in 2024, then surged by 66.1% to $2.1 million in 2025.
  • According to Business Quant data, Accumulated Depreciation & Amortization over the past three periods came in at $2.1 million, $1.9 million, and $1.7 million for Q4 2025, Q3 2025, and Q2 2025 respectively.